[1]
Zlatkina, V.V., Nesen, A.O. and Demikhova, N. V. 2026. Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 2: Metabolomic aspects of nephroprotection. Ukrainian Journal of Nephrology and Dialysis. 1(89) (Mar. 2026), 94-100. DOI:https://doi.org/10.31450/ukrjnd.1(89).2026.10.